Italy Cancer Diagnostics Market Segmentation Analysis, 2019-2023: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.
This new report is based on a study of the major business opportunities emerging in the Italian cancer diagnostics market during the next five years. The report examines trends in the Italian market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.
Rationale
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the Italian cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.
Italian Market Overview
- Five-year test volume and sales projections.
- Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers.
- Estimated universe of laboratories performing cancer diagnostic testing.
- Cancer statistics, etiology and recent developments in Italy.
Business Opportunities and Strategic Recommendations
- Specific new product development opportunities with potentially significant market appeal during the next five years.
- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Over 200 Current and Emerging Cancer Diagnostic Test
- Oncogenes
- Biochemical Markers
- Growth Factors
- Colony Stimulating Factors
- Hormones
- Immunohistochemical Stains
- Lymphokines
Supplier Shares, Sales and Volume Forecasts
- Sales and market shares of major cancer diagnostic product suppliers by individual test.
- Five-year test volume and sales forecasts for major tumor markers by market segment, including:
º Hospitals
º Commercial/Private Laboratories
Instrumentation Review
- Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.
Technology Assessment
- Assessment of latest technologies and their potential applications for cancer diagnostic testing.
- Review of competing/complementing technologies.
- Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies.
Competitive Strategies
- Strategic assessments of major suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.
Contains 570 pages and 83 tables
II. Worldwide Market Overview
A. Market Overview
B. Worldwide Market Structure
C. Worldwide Market Size and Growth
III. Major Product Development Opportunities
A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Worldwide Market and Technology Overview
A. Major Current and Emerging Cancer Diagnostic Tests
1. Biochemical Tumor Markers
2. Oncogenes
3. Polypeptide Growth Factors
4. Ectopic Hormones
5. Colony Stimulating Factors
6. Lymphokines
7. Immunohistochemical Stains
8. Emerging Tumor Markers
B. Instrumentation Review and Market Needs
C. Current and Emerging Technologies
D. Personal Testing
VIII. Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Test and Market Segment
- Sales Forecasts by Test and Market Segment
- Major Supplier Sales and Market Shares
IX. Competitive Profiles
- Abbott
- AdnaGen
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode Genetics
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group
- Epigenomics
- Enterix
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen/Ipsogen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Thermo Fisher
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila
X. Appendix: Major Universities and Research
Centers Developing Cancer Diagnostic
Technologies and Applications
List Of Tables
Cancer Diagnostic Classification
Major Companies Developing or Marketing
ACTH Tests
Major Companies Developing or Marketing
AFP Tests
Major Companies Developing or Marketing
Beta-2 Microglobulin Tests
Major Companies Developing or Marketing
CA 15-3/27.29 Tests
Major Companies Developing or Marketing
CA 19-9 Tests
Major Companies Developing or Marketing
CA 125 Tests
Major Companies Developing or Marketing
Calcitonin Tests
Major Companies Developing or Marketing
CEA Tests
Major Companies Developing or Marketing
Estrogen Receptor Tests
Major Companies Developing or Marketing
Progesterone Receptor Tests
Major Companies Developing or Marketing
Ferritin Tests
Major Companies Developing or Marketing
Gastrin Tests
Major Companies Developing or Marketing
HCG Tests
Major Companies Developing or Marketing
Insulin Tests
Major Companies Developing or Marketing
NSE Tests
Major Companies Developing or Marketing
Occult Blood Tests
Major Companies Developing or Marketing
PAP Smear/HPV Tests
Major Companies Developing or Marketing
PAP Tests
Major Companies Developing or Marketing
PSA Tests
Major Companies Developing or Marketing
Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications
In Cancer Diagnosis
Oncogenes Potential Applications
In Cancer Diagnosis
Major Companies Developing or Marketing
Oncogene Tests
Growth Factors Potential Applications
In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential
Applications in Cancer Diagnosis
Executive Summary Table: Italy, Total Cancer
Diagnostic Testing Volume and Diagnostics Sales
Forecasts by Market Segment
Italy, Estimated Cancer Death Rates
Italy, Laboratories Performing Cancer
Diagnostic Tests by Market Segment
Italy, Hospital Laboratories Performing
Cancer Diagnostic Tests by Bed Size
Italy, Commercial/Private Laboratories
Performing Cancer Diagnostics Tests
By Annual Test Volume
Italy, Total Cancer Diagnostic Test Volume
Forecasts by Market Segment
Italy, All Market Segments Major Cancer
Diagnostic Test Volume Forecasts by Test
Italy, Hospital Laboratories Major Cancer
Diagnostic Test Volume Forecasts
Italy, Commercial/Private Laboratories
Major Cancer Diagnostic Test Volume Forecasts
Italy, Total Cancer Diagnostic Test Market
Forecasts by Market Segment
Italy, All Market Segments Major Cancer
Diagnostic Sales Forecasts by Test
Italy, Hospital Laboratories Major
Cancer Diagnostic Forecasts by Test
Italy, Commercial/Private Laboratories
Major Cancer Diagnostic Sales Forecasts by Test
Italy, ACTH Test Volume and Diagnostics
Sales Forecasts by Market Segment
Italy, AFP Test Volume and Diagnostics
Sales Forecasts by Market Segment
Italy, Beta-2 Microglobulin Test Volume
And Diagnostics Sales Forecasts by Market Segment
Italy, CA 15-3/27.29 Test Volume and
Diagnostics Sales Forecasts by Market Segment
Italy, CA-19-9 Test Volume and Diagnostics
Sales Forecasts by Market Segment
Italy, CA 125 Test Volume and Diagnostics
Sales Forecasts by Market Segment
Italy, Calcitonin Test Volume and Diagnostics
Sales Forecasts by Market Segment
Italy, CEA Test Volume and Diagnostics Sales
Forecasts by Market Segment
Italy, Chromogranin Test Volume
And Diagnostics Sales Forecasts by Market Segment
Italy, Colon Specific Antigen Test Volume
And Diagnostics Sales Forecasts by Market Segment
Italy, Cytokeratins Test Volume and
Diagnostics Sales Forecasts by Market Segment
Italy, Estrogen Receptor Test Volume and
Diagnostics Sales Forecasts by Market Segment
Italy, Ferritin Test Volume and Diagnostics
Sales Forecasts by Market Segment
Italy, Gastrin Test Volume and Diagnostics
Sales Forecasts by Market Segment
Italy, HCG Test Volume and Diagnostics
Sales Forecasts by Market Segment
Italy, Insulin Test Volume and Diagnostics
Sales Forecasts by Market Segment
Italy, Lymphocyte Subtyping Test Volume
And Diagnostics Sales Forecasts by Market
Segment
Italy, NSE Test Volume and Diagnostics Sales
Forecasts by Market Segment
Italy, Occult Blood Test Volume and Diagnostics
Sales Forecasts by Market Segment
Italy, Oncogenes Test Volume and Diagnostics
Sales Forecasts by Market Segment
Italy, Pancreatic Oncofetal Antigen Test
Volume and Diagnostics Sales Forecasts
By Market Segment
Italy, PAP Smear Test Volume and
Diagnostics Sales Forecasts by Market Segment
Italy, Parathyroid Hormone Test Volume and
Diagnostics Sales Forecasts by Market Segment
Italy, Progesterone Receptor Test Volume and
Diagnostics Sales Forecasts by Market Segment
Italy, PAP Test Volume and Diagnostics Sales
Forecasts by Market Segment
Italy, PSA Test Volume and Diagnostics Sales
Forecasts by Market Segment
Italy, S-100 Test Volume and Diagnostics
Sales Forecasts by Market Segment
Italy, Serotonin Test Volume and
Diagnostics Sales Forecasts by Market Segment
Italy, Sialic Acid Test Volume and
Diagnostics Sales Forecasts by Market Segment
Italy, Squamous Cell Carcinoma Antigen Test
Volume and Diagnostics Sales Forecasts
By Market Segment
Italy, TDT Test Volume and Diagnostics Sales
Forecasts by Market Segment
Italy, Thymidine Kinase Test Volume and
Diagnostics Sales Forecasts by Market Segment
Italy, Thyroglobulin Test Volume and
Diagnostics Sales Forecasts by Market Segment
Italy, TPA Test Volume and Diagnostics Sales
Forecasts by Market Segment
Italy, Total Cancer Diagnostics
Sales by Major Suppliers
Italy, AFP Testing Market Diagnostics
Sales by Major Supplier
Italy, CEA Testing Market Diagnostics
Sales by Major Supplier
Italy, PSA Testing Market Diagnostics
Sales by Major Supplier
2020 Italy Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and Opportunities
This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the Italian molecular blood banking market during the next five years,
View Report2020 Europe Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation
This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European molecular blood banking market during the next five
View Report2020 Cancer Diagnostics Market: US, Europe, Japan--Supplier Shares by Test, Country Volume and Sales Forecasts, Profiles of Leading Competitors, Emerging Tumor Markers, Technology Assessment, Instrumentation Review
This new report provides analysis of the global cancer diagnostics market, including emerging tests, Technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents:Estimated
View Report2020 US Cancer Diagnostics Market: Supplier Shares by Test, Competitive Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation
It's new report is a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the US
View ReportFill The Form For Sample Request